Botulinum toxin type A injection into the masticatory muscles and its effects on mandibular bone resorption and density. A systematic review
- PMID: 39123075
- DOI: 10.1007/s00784-024-05838-5
Botulinum toxin type A injection into the masticatory muscles and its effects on mandibular bone resorption and density. A systematic review
Abstract
Objective: This systematic review aims to summarize and synthesize the evidence that investigates the secondary effects of the application of botulinum toxin (BT) into the masticatory muscles and its effects on bone density.
Materials and methods: Database searches were conducted until March 19th, 2024. The quality of the studies was assessed by the Cochrane tool risk of bias for the randomized controlled trials and the ROBINS-I tool for non-randomized studies. The Cochrane Grading of Recommendations Assessment Development and Evaluation (GRADE) was used to evaluate the confidence in the overall evidence.
Results: Five studies looking at the effects of botulinum toxin on bone density and resorption when applied to masticatory muscles were found. No significant changes were observed in most of the studies when looking at the effects of botulinum toxin on mandibular condyle volume, density, mandibular angle thickness, and coronoid process volume. The only finding that was statistically and clinically relevant was the difference between patients who received a double application of BT when compared with patients who received a single application (SMD: -0.99 [95%CI: -1.94,-0.05]) on the volume of the mandibular angle.
Conclusions: There is no clear pattern on whether the application of botulinum toxin is associated with bone resorption or not. Although some studies show statistical significance of the findings, the magnitude of the changes in bone density and their clinical significance are not completely clear.
Clinical relevance: To understand the effectiveness of the use of botulinum toxin into the masticatory muscles and its possible secondary adverse effects on the density of the mandible.
Keywords: Botox; Botulinum toxin; Coronoid process; Mandibular condyle; Osteopenia; bOne density.
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
Impact of botulinum toxin injection into the masticatory muscles on mandibular bone: A systematic review.J Oral Rehabil. 2022 Jun;49(6):644-653. doi: 10.1111/joor.13326. Epub 2022 Apr 9. J Oral Rehabil. 2022. PMID: 35348239
-
Botulinum toxin type A therapy for cervical dystonia.Cochrane Database Syst Rev. 2017 Dec 12;12(12):CD003633. doi: 10.1002/14651858.CD003633.pub3. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2020 Nov 12;11:CD003633. doi: 10.1002/14651858.CD003633.pub4. PMID: 29230798 Free PMC article. Updated.
-
Botulinum toxin type A versus botulinum toxin type B for cervical dystonia.Cochrane Database Syst Rev. 2016 Oct 26;10(10):CD004314. doi: 10.1002/14651858.CD004314.pub3. Cochrane Database Syst Rev. 2016. PMID: 27782297 Free PMC article.
-
Botulinum toxin type B for cervical dystonia.Cochrane Database Syst Rev. 2016 May 13;2016(5):CD004315. doi: 10.1002/14651858.CD004315.pub3. Cochrane Database Syst Rev. 2016. PMID: 27176573 Free PMC article.
-
Treatment for sialorrhea (excessive saliva) in people with motor neuron disease/amyotrophic lateral sclerosis.Cochrane Database Syst Rev. 2022 May 20;5(5):CD006981. doi: 10.1002/14651858.CD006981.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593746 Free PMC article.
References
-
- Serrera-Figallo MA et al (2020) Use of botulinum toxin in orofacial clinical practice. Toxins (Basel) 12(2):1–16. https://doi.org/10.3390/toxins12020112
-
- Ziegler CM, Haag C, Mühling J (2003) Treatment of recurrent temporomandibular joint dislocation with intramuscular botulinum toxin injection. Clin Oral Investig 7(1):52–55. https://doi.org/10.1007/s00784-002-0187-y - PubMed
-
- Intiso D (2012) Therapeutic use of botulinum toxin in neurorehabilitation. J Toxicol 2012(1):802893. https://doi.org/10.1155/2012/802893 - PubMed
-
- De la Torre Canales G et al (2020) Efficacy and safety of botulinum toxin type A on persistent myofascial pain: a randomized clinical trial. Toxins 12(6):395. https://doi.org/10.3390/toxins12060395 - PubMed - PMC
-
- Zhang LD, Liu Q, Zou DR, Yu LF (2016) Occlusal force characteristics of masseteric muscles after intramuscular injection of botulinum toxin A (BTX–A) for treatment of temporomandibular disorder. Br J Oral Maxillofac Surg 54(7):736–740. https://doi.org/10.1016/j.bjoms.2016.04.008 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical